In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

“We have seen steady growth in the use of Cortrophin Gel as an adjunctive therapy for gout flares since we launched our 1-mL vial, which we developed to help increase access for in-office treatment, ...

The current US FDA drug label for pegloticase includes warnings for anaphylaxis, infusion reactions, congestive heart failure and gout flares. 10 The objective of this study was to describe the ...

These can help prevent gout flares and further complications. According to the American College of Rheumatology guidelines, allopurinol is the first-line medication for lowering uric acid levels.

A treat-to-target approach with incremental urate-lowering therapy (ULT) dose titration and flare prophylaxis was shown to mitigate the risk for gout flares during the initiation and titration of ...

The 2020 Gout Treatment Guidelines from the American College of Rheumatology recommend the use of flare prophylaxis for at least 3 to 6 months after starting ULT.

The goals of therapy in gout include not simply active and rapid treatment of acute gout flares but also prevention of acute gout attacks, whose major precipitating factors are listed in Table 9-1 ...

Growing evidence suggests that a guideline-directed, treat-to-target strategy in patients with gout not only controls the disease but also reduces cardiovascular risks.

Background: Gout is the most prevalent inflammatory arthritis, yet it remains undertreated despite affordable and effective treatment options. High quality data evaluating current gout management and ...

Objective Gout is associated with lifestyle, body mass index (BMI) and comorbidities, including dyslipidaemia. We studied how in actively treated patients, anthropometric measures and lipid levels ...